Strides Pharma Science Limited (BOM:532531)
India flag India · Delayed Price · Currency is INR
844.70
-9.60 (-1.12%)
At close: Jun 19, 2025

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
Pharmaceutical
40.51B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
9.83%
Log In
Log In
Log In
Log In
Upgrade
Services
-
Log In
Log In
Log In
Log In
Upgrade
Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
Other
116.12M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-19.33%
Log In
Log In
Log In
Log In
Upgrade
North America
21.48B
Log In
Log In
Log In
Log In
Upgrade
North America Growth
11.50%
Log In
Log In
Log In
Log In
Upgrade
Europe
9.20B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
9.87%
Log In
Log In
Log In
Log In
Upgrade
Africa
3.91B
Log In
Log In
Log In
Log In
Upgrade
Africa Growth
-13.30%
Log In
Log In
Log In
Log In
Upgrade
Australia
3.71B
Log In
Log In
Log In
Log In
Upgrade
Australia Growth
19.11%
Log In
Log In
Log In
Log In
Upgrade
Global
1.60B
Log In
Log In
Log In
Log In
Upgrade
Global Growth
98.35%
Log In
Log In
Log In
Log In
Upgrade
India
331.28M
Log In
Log In
Log In
Log In
Upgrade
India Growth
51.53%
Log In
Log In
Log In
Log In
Upgrade
Asia (excluding India)
172.38M
Log In
Log In
Log In
Log In
Upgrade
Asia (excluding India) Growth
-62.57%
Log In
Log In
Log In
Log In
Upgrade
Other
116.12M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-19.33%
Log In
Log In
Log In
Log In
Upgrade